These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 1929448)
41. [Preoperative chemotherapy for advanced colorectal carcinomas--comparison of histological effect between UFT + leucovorin tablet and UFT alone]. Maruyama M; Kudo T; Kuwabara H; Yoshida T; Sugano N; Ebuchi M Gan To Kagaku Ryoho; 1998 Apr; 25(5):691-6. PubMed ID: 9571966 [TBL] [Abstract][Full Text] [Related]
42. [Level of 5-FU in tumor tissues of the patients with head and neck malignant tumors after oral administration of UFT]. Kusama M; Utsunomiya Y; Ono T; Nagura H; Enomoto S Gan To Kagaku Ryoho; 1983 Aug; 10(8):1796-802. PubMed ID: 6411004 [TBL] [Abstract][Full Text] [Related]
43. [Evaluation of UFT administration in patients with ovarian cancer who had no evidence of disease after the initial therapy]. Chen JT; Nakayama K; Shimizu Y; Yokosuka K; Teshima H; Hirai Y; Hamada T; Fujimoto I; Yamauchi K; Hasumi K Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):407-12. PubMed ID: 2106837 [TBL] [Abstract][Full Text] [Related]
44. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. Lembersky BC; Wieand HS; Petrelli NJ; O'Connell MJ; Colangelo LH; Smith RE; Seay TE; Giguere JK; Marshall ME; Jacobs AD; Colman LK; Soran A; Yothers G; Wolmark N J Clin Oncol; 2006 May; 24(13):2059-64. PubMed ID: 16648506 [TBL] [Abstract][Full Text] [Related]
45. [5-FU concentration in the tissues (tumor and lymph node) of breast cancer patients given preoperative administration of UFT and FT]. Koida T; Kimura M Gan To Kagaku Ryoho; 1985 May; 12(5):1147-51. PubMed ID: 3922313 [TBL] [Abstract][Full Text] [Related]
46. Chronopharmacokinetics of oral tegafur and uracil in colorectal cancer patients. Etienne-Grimaldi MC; Cardot JM; François E; Renée N; Douillard JY; Gamelin E; Milano G Clin Pharmacol Ther; 2008 Mar; 83(3):413-5. PubMed ID: 17637782 [TBL] [Abstract][Full Text] [Related]
47. [Pharmacokinetic study in biochemical modulation therapy of UFT with leucovorin tablet]. Yamamura T; Oikawa H; Hanai A; Matsuzaki H; Akaishi O; Seo K; Kikuchi K; Ozasa T; Tsukikawa S; Yamaguchi S Gan To Kagaku Ryoho; 1995 Feb; 22(2):245-51. PubMed ID: 7857100 [TBL] [Abstract][Full Text] [Related]
48. [Determination of 5-FU tissue concentrations after oral UFT administration in tumors of the head and neck]. Somekawa Y; Asano K; Taira A; Imai R Gan To Kagaku Ryoho; 1996 Jan; 23(1):75-9. PubMed ID: 8546473 [TBL] [Abstract][Full Text] [Related]
49. [The effect of gastrectomy on serum 5-FU concentrations of patients administered UFT per os]. Yamamoto Y; Amano T; Fujimoto Y; Imada T; Tamura S; Noguchi Y; Matsumoto A Gan No Rinsho; 1987 Apr; 33(4):377-81. PubMed ID: 3106673 [TBL] [Abstract][Full Text] [Related]
50. [5-FU concentration in tissues of gastric cancer patients with preoperative administration of UFT--especially in comparison with FT-207]. Takeshita M; Ishikawa H; Seki M; Ikeya T; Miyamoto Y; Izuo M; Tozuka S; Usui R; Kaneko H Gan No Rinsho; 1985 Oct; 31(13):1697-703. PubMed ID: 3935831 [TBL] [Abstract][Full Text] [Related]
51. [5-Fluorouracil concentration in various tissues from cancer patients after oral administration of 5-fluorouracil]. Nakamura T; Hashimoto I; Sawada Y; Mikami J; Yoshimoto M; Nishidai H; Nakanishi Y; Kashi Y Gan To Kagaku Ryoho; 1984 May; 11(5):1037-48. PubMed ID: 6721512 [TBL] [Abstract][Full Text] [Related]
52. [Studies on tissue concentration of tegafur, 5-fluorouracil, uracil after UFT administration together with the study of microangiography of colorectal cancer]. Shimoyama T; Shimizu T; Kusano H; Ishikawa H; Miyashita K; Nakazaki T; Yasutake T; Yoshida A; Yoshida K; Ogawa T Gan To Kagaku Ryoho; 1993 Jan; 20(1):125-30. PubMed ID: 8422176 [TBL] [Abstract][Full Text] [Related]
53. [A multicenter cooperative study on supplementary chemotherapy of uterocervical cancer. The Kyushu UFT Study Group of Uterocervical Cancer]. Kato T; Yakushiji M; Yamabe T; Sugimori H; Hidaki T; Tsukamoto N; Tazaki T Gan To Kagaku Ryoho; 1994 Jul; 21(8):1221-7. PubMed ID: 8031165 [TBL] [Abstract][Full Text] [Related]
54. [Three cases of metastatic breast cancer, resistant to pre-chemo and/or endocrine therapy, markedly improved with UFT and cyclophosphamide oral combination therapy]. Ogawa Y; Ishikawa T; Ogisawa K; Ikeda K; Nagatsuka I; Matsumura Y; Takashima T; Yashiro M; Onoda N; Nakata B; Kato Y; Hirakawa K Gan To Kagaku Ryoho; 2000 Nov; 27(13):2123-7. PubMed ID: 11103246 [TBL] [Abstract][Full Text] [Related]
55. [FT, 5-FU and uracil concentrations of the blood, bile and tissue of hepatoma with liver cirrhosis after oral administration of UFT]. Oguma S; Sakai K; Sato R; Ouchi K; Owada Y; Sato T Gan To Kagaku Ryoho; 1987 Apr; 14(4):1122-8. PubMed ID: 3032114 [TBL] [Abstract][Full Text] [Related]
56. [Two metastatic colonic cancer patients successfully treated by combination therapy of tegafur/uracil (UFT) and oral Leucovorin]. Ina K; Kataoka T; Ohkita T; Nagao S; Ito A; Inagaki J; Kato H; Ando T; Niwa Y; Goto H Gan To Kagaku Ryoho; 2006 Oct; 33(10):1469-71. PubMed ID: 17033240 [TBL] [Abstract][Full Text] [Related]
57. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting]. Inaji H; Sakai K; Oka T; Ozawa K; Saito Y; Senoo T; Taguchi T; Terasawa T; Nakao K; Mori T; Koyama H; Oshima A Gan To Kagaku Ryoho; 2006 Oct; 33(10):1423-9. PubMed ID: 17033231 [TBL] [Abstract][Full Text] [Related]
58. [Studies on 5-FU concentration in serum and bladder tumor tissue after oral administration of UFT]. Takayama H; Konami T; Konishi T; Pak K; Tomoyoshi T Hinyokika Kiyo; 1986 Oct; 32(10):1449-53. PubMed ID: 3105272 [TBL] [Abstract][Full Text] [Related]
59. [Antitumor effect of UFT on human ovarian cancer grafted to nude mice and 5-FU concentration in tumor and normal tissues]. Yoshiya N; Adachi S; Misawa Y; Ishida M; Yuzawa H; Kanazawa K; Takeuchi S Gan To Kagaku Ryoho; 1988 Feb; 15(2):285-9. PubMed ID: 3124768 [TBL] [Abstract][Full Text] [Related]
60. [Low-dose cisplatin added to continuous infusion of 5-fluorouracil or oral administration of UFT for inoperable advanced or recurrent colorectal cancer]. Asano M; Mori T; Takahashi K; Yasuno M Gan To Kagaku Ryoho; 1997 Jan; 24(1):55-60. PubMed ID: 9020946 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]